<code id='88C751DE5D'></code><style id='88C751DE5D'></style>

<acronym id='88C751DE5D'></acronym>

<center id='88C751DE5D'><center id='88C751DE5D'><tfoot id='88C751DE5D'></tfoot></center><abbr id='88C751DE5D'><dir id='88C751DE5D'><tfoot id='88C751DE5D'></tfoot><noframes id='88C751DE5D'>

<optgroup id='88C751DE5D'><strike id='88C751DE5D'><sup id='88C751DE5D'></sup></strike><code id='88C751DE5D'></code></optgroup>

<b id='88C751DE5D'><label id='88C751DE5D'><select id='88C751DE5D'><dt id='88C751DE5D'><span id='88C751DE5D'></span></dt></select></label></b><u id='88C751DE5D'></u>

~~<i id='88C751DE5D'><strike id='88C751DE5D'><tt id='88C751DE5D'><pre id='88C751DE5D'></pre></tt></strike></i>~~

Home» explore» focus

focus

focus

author：focus 2025-09-28 15:44:32 Page View：279

Adobe

LONDON — GSK said Tuesday it would purchase the asthma-focused drug developer Aiolos Bio for $1 billion upfront, the latest in a string of pharma acquisitions that are bolstering hopes for the industry’s year ahead.

The deal includes up to another $400 million in payments if certain milestones are met.

advertisement

Aiolos was launched just last year, based in both San Francisco and London. The company, which announced a $245 million Series A round in October, has been readying a Phase 2 trial of its candidate AIO-001 in adult asthma.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicaid rebukes states for mistakenly disenrolling children
Next article： ChatGPT in medicine: STAT answers readers' burning questions

explore

Bright Health sells Medicare Advantage business to Molina

Bright Health sells Medicare Advantage business to Molina

BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

Illumina names Agilent executive as new CEO

Illumina names Agilent executive as new CEO

AdobeIllumina,thelargestmakerofDNA-sequencingtechnologyandastoriednameinthebiotechnologyindustry,nam

What does generative AI mean for health care? We asked experts

What does generative AI mean for health care? We asked experts

MikeReddyforSTATHealthcarecompaniesareracingtoincorporategenerativeAItoolsintotheirproductpipelinesa

How to fix cancer clinical trials' diversity problem

Clockwisefromtopleft:STAT'sNicholasSt.Fleur(moderator);JudySewards,headofclinicaltrialexperienceatPf

read more